The population of Alberta is aging and there are increasing numbers of Albertans who are affected by Alzheimer’s disease and other types of dementia. At the present time little is known about the numbers of people affected by dementia in Alberta or how they interact with the health care system. Understanding the health care journeys of people with dementia is a critical step in understanding how to plan supports and services for people affected by Alzheimer’s disease and their families. Although there are medications currently approved for the treatment of Alzheimer’s disease in Canada, these medications only produce temporary benefits on dementia symptoms and do not change the underlying disease course. However, research on treatments that may impact on the underlying disease course of Alzheimer’s disease (disease modifying therapies) are nearing the phase where these treatments may be approved for use in Canada in the near future. These new treatments will require that physicians and health services are prepared to offer these medications and safely monitor their use Canada. Understanding how physicians and other health care providers currently assess and manage dementia is important to prepare our health system to be ready for when these new treatments once they are approved for use in Canada. Overall, our project will describe the current state of people impacted by Alzheimer’s disease in Alberta and identify strategies that may be used to help implement new dementia treatments that may be approved by Health Canada in the future.